Medical Device News Magazine

David Kroekel Appointed Enable Injections COO

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

David Kroekel

Enable Injections, Inc. (“Enable”), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery systems, today announced the appointment of David Kroekel, previously Senior Vice President, Product Development and Operations at Enable, to Chief Operating Officer. In this critical position, Mr. Kroekel will play an important role leading the ongoing engineering, manufacturing, and supply of the Company’s enFuse technology.

Mike Hooven, Chairman and CEO of Enable Injections

“David Kroekel brings a wealth of experience in cross-functional collaboration, infrastructure development, and engineering excellence in medical device manufacturing and development. In the past year, Enable has poised itself for long-term commercial success and increasing product demand – with the U.S. FDA approval of the Company’s first enFuse combination product, and three high-value collaborations with both new and existing partners. David’s leadership at Enable has played a pivotal role in our Company’s success to date and we are excited to have him in this new position as COO as we continue driving innovation for enFuse and bringing this game-changing technology to our partners, HCPs, and most importantly – patients.”

Wealth of Experience

David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development. Prior to Enable, Mr. Kroekel was the Biomedical Global Head of Operations at DSM Biomedical, responsible for global leadership of biologics and medical materials manufacturing, and also previously served as the Sr. Director of Innovation, where he led new product development and innovation. Prior to DSM, Mr. Kroekel held various senior positions in the medical device industry for companies like Flowonix Medical, Teleflex Medical, and Arrow International’s EMEA business unit in Belgium. Mr. Kroekel earned a Bachelor of Science in Mechanical Engineering from Pennsylvania State University and a Master of Science in Manufacturing Systems Engineering from Lehigh University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”